Latest debt-to-equity ratio
Spero Therapeutics Debt-to-equity ratio
Direct answer
Spero Therapeutics's debt-to-equity ratio is 4.62%.
The verified market snapshot reports 4.62%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 28, 2026.
Get free Spero Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 4.62%
Explore related company data
View Spero Therapeutics's market capitalizationView Spero Therapeutics's p/e ratioView Spero Therapeutics's price-to-book ratioView Spero Therapeutics's return on equityView Spero Therapeutics's 52-week price rangeView Spero Therapeutics's profit marginView all Spero Therapeutics key metricsReturn to Spero Therapeutics profile